Teprotumumab for the Treatment of Active Thyroid Eye Disease von Douglas, Raymond S, Kahaly, George J, Patel, Amy, Sile, Saba, Thompson, Elizabeth H.Z, Perdok, Renee, Fleming, James C, Fowler, Brian T, Marcocci, Claudio, Marinò, Michele, Antonelli, Alessandro, Dailey, Roger, Harris, Gerald J, Eckstein, Anja, Schiffman, Jade, Tang, Rosa, Nelson, Christine, Salvi, Mario, Wester, Sara, Sherman, Jeffrey W, Vescio, Thomas, Holt, Robert J, Smith, Terry J

Volltext

Teprotumumab, an IGF-1R Blocking Monoclonal Antibody Inhibits TSH and IGF-1 Action in Fibrocytes von Chen, Hong, Mester, Tünde, Raychaudhuri, Nupur, Kauh, Courtney Y, Gupta, Shivani, Smith, Terry J, Douglas, Raymond S

Volltext

Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves’ orbitopathy von Smith, Terry J., M.D, Hegedüs, Laszlo, M.D., DMSc, Douglas, Raymond S., M.D., Ph.D

Volltext

Evidence for an Association between Thyroid-Stimulating Hormone and Insulin-Like Growth Factor 1 Receptors: A Tale of Two Antigens Implicated in Graves' Disease von Tsui, Shanli, Naik, Vibha, Hoa, Neil, Hwang, Catherine J, Afifiyan, Nikoo F, Sinha Hikim, Amiya, Gianoukakis, Andrew G, Douglas, Raymond S, Smith, Terry J

Volltext

Human fibrocytes coexpress thyroglobulin and thyrotropin receptor von Fernando, Roshini, Atkins, Stephen, Raychaudhuri, Nupur, Lu, Ying, Li, Bin, Douglas, Raymond S, Smith, Terry J

Volltext

Increased Generation of Fibrocytes in Thyroid-Associated Ophthalmopathy von Douglas, Raymond S, Afifiyan, Nikoo F, Hwang, Catherine J, Chong, Kelvin, Haider, Uzma, Richards, Patrick, Gianoukakis, Andrew G, Smith, Terry J

Volltext

Teprotumumab, an insulin-like growth factor-1 receptor antagonist antibody, in the treatment of active thyroid eye disease: a focus on proptosis von Douglas, Raymond S.

Volltext

A New Era in the Treatment of Thyroid Eye Disease von Patel, Amy, Yang, Huasheng, Douglas, Raymond S.

Volltext

TSH-Mediated TNFα Production in Human Fibrocytes Is Inhibited by Teprotumumab, an IGF-1R Antagonist von Chen, Hong, Shan, Shannon J C, Mester, Tünde, Wei, Yi-Hsuan, Douglas, Raymond S

Volltext

PGE2 induces IL-6 in orbital fibroblasts through EP2 receptors and increased gene promoter activity: implications to thyroid-associated ophthalmopathy von Raychaudhuri, Nupur, Douglas, Raymond S, Smith, Terry J

Volltext

Teprotumumab for the Treatment of Thyroid Eye Disease von Ugradar, Shoaib, Malkhasyan, Emil, Douglas, Raymond S

Volltext

Rituximab Treatment of Patients with Severe, Corticosteroid-Resistant Thyroid-Associated Ophthalmopathy von Khanna, Dinesh, MD, MS, Chong, Kelvin K.L., MD, FCOphth, Afifiyan, Nikoo F., PhD, Hwang, Catherine J., MD, Lee, Diana K., BS, Garneau, Helene Chokron, BA, Goldberg, Robert A., MD, Darwin, Christine H., MD, Smith, Terry J., MD, Douglas, Raymond S., MD, PhD

Volltext

CD40 Expression in Fibrocytes Is Induced by TSH: Potential Synergistic Immune Activation von Mester, Tünde, Raychaudhuri, Nupur, Gillespie, Erin F, Chen, Hong, Smith, Terry J, Douglas, Raymond S

Volltext

Facial and Eyelid Changes in Thyroid Eye Disease Are Reversed by Teprotumumab von Ugradar, Shoaib, Braun, Jenna, Wang, Yao, Zimmerman, Erin, Douglas, Raymond S.

Volltext

Orbital fibrosis in a mouse model of Graves' disease induced by genetic immunization of thyrotropin receptor cDNA von Zhao, Shuang-Xia, Tsui, Shanli, Cheung, Anthony, Douglas, Raymond S, Smith, Terry J, Banga, J Paul

Volltext

Immunopathogenesis of Thyroid Eye Disease: Emerging Paradigms von Naik, Vibhavari M., MD, Naik, Milind N., MD, Goldberg, Robert A., MD, FACS, Smith, Terry J., MD, Douglas, Raymond S., MD, PhD

Volltext

Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placeb... von Kahaly, George J, Douglas, Raymond S, Holt, Robert J, Sile, Saba, Smith, Terry J

Volltext

Proptosis and Diplopia Response With Teprotumumab and Placebo vs the Recommended Treatment Regimen With Intravenous Methylprednisolone in Moderate to Severe Thyroid Eye Disease: A... von Douglas, Raymond S, Dailey, Roger, Subramanian, Prem S, Barbesino, Giuseppe, Ugradar, Shoaib, Batten, Ryan, Qadeer, Rana A, Cameron, Chris

Volltext

Teprotumumab for Thyroid-Associated Ophthalmopathy von Smith, Terry J, Kahaly, George J, Ezra, Daniel G, Fleming, James C, Dailey, Roger A, Tang, Rosa A, Harris, Gerald J, Antonelli, Alessandro, Salvi, Mario, Goldberg, Robert A, Gigantelli, James W, Couch, Steven M, Shriver, Erin M, Hayek, Brent R, Hink, Eric M, Woodward, Richard M, Gabriel, Kathleen, Magni, Guido, Douglas, Raymond S

Volltext

Nuclear targeting of IGF-1 receptor in orbital fibroblasts from Graves' disease: apparent role of ADAM17 von Hoa, Neil, Tsui, Shanli, Afifiyan, Nikoo F, Sinha Hikim, Amiya, Li, Bin, Douglas, Raymond S, Smith, Terry J

Volltext